Robert Zerbe - Apr 27, 2023 Form 4 Insider Report for Vericel Corp (VCEL)

Role
Director
Signature
/s/ Sean Flynn, as Attorney-in-Fact for Robert Zerbe
Stock symbol
VCEL
Transactions as of
Apr 27, 2023
Transactions value $
$0
Form type
4
Date filed
4/28/2023, 04:04 PM
Previous filing
Mar 3, 2023
Next filing
May 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VCEL Common Stock Options Exercise +2.6K +7.47% 37.4K Apr 27, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VCEL Restricted Stock Unit Options Exercise $0 -2.6K -100% $0.00* 0 Apr 27, 2023 Common Stock 2.6K Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on April 27, 2022.
F2 Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation.
F3 These RSUs vest 100% on the earlier of April 27, 2023 or the date of the first Annual Meeting of Stockholders following April 27, 2022.
F4 No expiration date for this type of award.